Issue 4/2016

Protein synthesis inhibitors of natural origin for CML therapy: semisynthetic homoharringtonine (Omacetaxine mepesuccinate) (495 — 503)

L. NOVOTNY, N. F. AL-TANNAK, L. HUNAKOVA

DOI: 10.4149/neo_2016_401

Smoking, hormonal factors and molecular markers in female lung cancer (504 — 509)

D. SCHVEIGERT, A. KRASAUSKAS, J. DIDZIAPETRIENE, D. KALIBATIENE, S. CICENAS

DOI: 10.4149/neo_2016_402

Malignant melanoma: diagnosis, treatment and cancer stem cells (510 — 517)

Z. KOZOVSKA, V. GABRISOVA, L. KUCEROVA

DOI: 10.4149/neo_2016_403

DNA from microdissected tissues may be extracted and stored on microscopic slides (518 — 522)

M. KORABECNA, P. STEINER, M. JIRKOVSKA

DOI: 10.4149/neo_2016_404

Daidzein exerts anti-tumor activity against bladder cancer cells via inhibition of FGFR3 pathway (523 — 531)

Y. HE, X. WU, Y. CAO, Y. HOU, H. CHEN, L. WU, L. LU, W. ZHU, Y. GU

DOI: 10.4149/neo_2016_405

Resveratrol inhibits hypoxia-induced glioma cell migration and invasion by the p-STAT3/miR-34a axis (532 — 539)

H. WANG, H. FENG, Y. ZHANG

DOI: 10.4149/neo_2016_406

Knockdown of 14-kDa phosphohistidine phosphatase expression suppresses lung cancer cell growth in vivo possibly through inhibition of NF-κB signaling pathway (540 — 547)

A. XU, X. LI, S. WU, T. LV, Q. JIN, L. SUN, J. HUANG

DOI: 10.4149/neo_2016_407

Significant prognostic values of nuclear genes encoding mitochondrial complex I subunits in tumor patients (548 — 558)

L. D. LI, H. F. SUN, Y. BAI, S. P. GAO, H. L. JIANG, W. JIN

DOI: 10.4149/neo_2016_408

Genes and pathways identified in thyroid carcinoma based on bioinformatics analysis (559 — 568)

J. W. YU, W. MAI, Y. L. CUI, L. Y. KONG

DOI: 10.4149/neo_2016_409

Aptamer-modified PLGA nanoparticle delivery of triplex forming oligonucleotide for targeted prostate cancer therapy (569 — 575)

J. JIAO, Q. ZOU, M. H. ZOU, R. M. GUO, S. ZHU, Y. ZHANG

DOI: 10.4149/neo_2016_410

Prognostic significance of miR-23b in combination with P-gp, MRP and LRP/MVP expression in non-small cell lung cancer (576 — 587)

M. JANIKOVA, V. ZIZKOVA, J. SKARDA, G. KHARAISHVILI, L. RADOVA, Z. KOLAR

DOI: 10.4149/neo_2016_411

Expression of ER stress markers (GRP78/BiP and PERK) in patients with tongue cancer (588 — 594)

K. KAIRA, M. TOYODA, A. SHIMIZU, K. MORI, M. SHINO, K. SAKAKURA, Y. TAKAYASU, K. TAKAHASHI, T. OYAMA, T. ASAO, K. CHIKAMATSU

DOI: 10.4149/neo_2016_412

Prognostic factors to predict outcome of reduced intensity allogeneic haematopoietic cell transplantation for chronic lymphocytic leukemia (595 — 600)

P. JINDRA, L. RAIDA, D. LYSAK, M. KARAS, T. PAPAJIK, A. JUNGOVA, L. MOHAMMADOVÁ, L. HOUDOVA

DOI: 10.4149/neo_2016_413

Cardiac tamponade – unusual clinical manifestation of undiagnosed malignant neoplasm (601 — 606)

B. PEREK, I. TOMASZEWSKA, S. STEFANIAK, I. KATYNSKA, M. JEMIELITY

DOI: 10.4149/neo_2016_414

Efficacy of intra-arterial neoadjuvant chemotherapy through the superior epigastric artery in the treatment of locally advanced triple negative breast cancer (607 — 616)

H. Y. JIN, W. HE, Q. LIU, X. F. WANG, Y. F. LIU, Z. X. WEI

DOI: 10.4149/neo_2016_415

Electroneurography in the evaluation of oxaliplatin-induced neuropathy in colorectal cancer patients (617 — 622)

A. L. ZYGULSKA, M. BANACH, K. KRZEMIENIECKI

DOI: 10.4149/neo_2016_416

Analysis of circulating miRNAs 21 and 375 as potential biomarkers for early diagnosis of prostate cancer (623 — 628)

Y. GAO, Y. GUO, Z. WANG, Z. DAI, Y. XU, W. ZHANG, Z. LIU, S. LI

DOI: 10.4149/neo_2016_417

Genetic variants and risk of prostate cancer using pathway analysis of a genome-wide association study (629 — 634)

Y. S. KIM, Y. KIM, J. W. CHOI, H. E. OH, J. H. LEE

DOI: 10.4149/neo_2016_418

Indication of pre-surgical radiochemotherapy enhances psychosocial morbidity among patients with resectable locally advanced rectal cancer (635 — 641)

V. BENCOVA, I. KRAJCOVICOVA, J. SVEC

DOI: 10.4149/neo_2016_419

Stage of bladder cancer in Central Europe – Polish perspective (642 — 647)

S. POLETAJEW, R. BIERNACKI, P. BURACZYNSKI, J. CHOJNACKI, S. CZARNIECKI, D. GAJEWSKA, T. POHABA, J. SONDKA, M. SKRZYPCZYK, T. SUCHOJAD, D. WOJTKOWIAK, B. ZAFOREMSKI, L. ZAPALA, A. ZEMLA, P. RADZISZEWSKI

DOI: 10.4149/neo_2016_420